Antimalarial drug resistance in the Eastern Mediterranean Region
(East. Mediterr. health j).
em Inglês
| WHO IRIS
| ID: who-119301
Biblioteca responsável:
CH1.1
ABSTRACT
Studies done between 1997 and 2003 are reviewed to give an overall picture of antimalarial drug resistance in the Eastern Mediterranean Region of the World Health Organization [WHO]. The situation in 8 countries where resistance has been reported is detailed. It has been difficult to abandon chloroquine as first-line treatment even though resistance to it is widespread. Resistance to sulfadoxine-pyrimethamine has also been detected. The spread of resistance could be slowed down by the adoption of effective national policies and control programmes. Coordination between counties and with other WHO regions, as opposed to working in isolation, could further reduce the spread of resistance
Texto completo:
Disponível
Coleções:
Bases de dados de organismos internacionais
Contexto em Saúde:
ODS3 - Meta 3.8 Atingir a cobertura universal de saúde
/
ODS3 - Saúde e Bem-Estar
/
Doenças Negligenciadas
Problema de saúde:
Arranjos de Governança
/
Meta 3.8 Atingir a cobertura universal de saúde
/
Malária
/
Doenças Negligenciadas
Base de dados:
WHO IRIS
Assunto principal:
Plasmodium falciparum
/
Polimorfismo Genético
/
Marcadores Genéticos
/
Cloroquina
/
Prevalência
/
Malária Falciparum
/
Monitoramento de Medicamentos
/
Doenças Endêmicas
/
Testes de Sensibilidade Parasitária
/
Política de Saúde
Idioma:
Inglês
Revista:
East. Mediterr. health j
Ano de publicação:
2003
